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Skin Sensitization to p-Phenylenediamine: The
Diverging Roles of Oxidation and N-Acetylation for
Dendritic Cell Activation and the Immune Response
Pierre Aeby1, Thomas Sieber1, Heinz Beck1, G. Frank Gerberick2 and Carsten Goebel3
Skin is a target of allergic reactions to aromatic amine hair dye precursors, such as p-phenylenediamine (PPD).
As conversion of PPD on or in the skin is expected to be required for the induction of allergic contact
dermatitis, we analyzed the role of oxidation and N-acetylation as major transformation steps. PPD and its
oxidative and N-acetylated derivatives were tested for their sensitizing potential in vitro using a dendritic cell
(DC) activation assay and in vivo using the local lymph node assay (LLNA). PPD did not induce relevant DC
activation but induced a positive LLNA response. In contrast, DC activation was obtained when PPD was
chemically pre-oxidized or after air oxygen exposure. Under both conditions, the potent sensitizing PPD
oxidation product Bandrowski’s base was identified along with other di- and trimeric species, indicating that
PPD oxidation products provide an effective immune stimulation (danger signal). In contrast mono- and
diacetylated PPD did not induce DC activation or a positive LLNA response. We conclude that dermal
N-acetylation of PPD competes with the formation of oxidized PPD whereas skin exposure conditions allowing
auto-oxidation, as in the LLNA, provide an effective danger signal necessary to induce skin sensitization to PPD.
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INTRODUCTION
The sensitizing potency of p-phenylenediamine (PPD) has
been well established in animal studies, such as the local
lymph node assay (LLNA; Warbrick et al., 1999) and guinea
pig tests (Xie et al., 2000). In addition, PPD has been
demonstrated to be a human allergen based on numerous
studies reported in the literature (Marzulli and Maibach,
1974; Sosted et al., 2006; Koopmans and Bruynzeelm, 2003;
Jerschow et al., 2001). In many of the animal studies
(Warbrick et al., 1999; Xie et al., 2000) and one human
study (Marzulli and Maibach, 1974), PPD is repeatedly
applied topically and remains on the skin for several days.
This exposure scenario would also apply to the diagnostic test
procedure used to determine if patients have a skin allergy to
PPD (Friedmann, 2007). In most instances, the PPD elicita-
tion response is analyzed after a single application followed
by a 48-hour exposure period (diagnostic patch test; Koop-
mans and Bruynzeelm, 2003; Friedmann, 2007).
However, despite the routine use of PPD in these assays,
the mechanism of the induction or elicitation of skin
sensitization by PPD is poorly understood on a chemical
basis, that is, the molecular alterations of PPD responsible for
its immunogenicity are not yet identified (Basketter and
Goodwin, 1988; Basketter and Liden, 1992; White et al.,
2006).
This lack of knowledge is presumably due to the complex
oxidation properties of PPD when it is exposed to air oxygen
for a prolonged period on the skin or in solution according to
the prehapten concept recently introduced by Lepoittevin
(2006). This concept suggests that the auto-oxidation of PPD
by air oxygen is pivotal for its immunogenicity. Accordingly,
several (auto) oxidation products have been proposed to be
responsible for skin sensitization to PPD such as the trimer
Bandrowski’s base (BB) and the monomer benzoquinone
(Krasteva et al., 1993; Lisi and Hansel, 1998), but no clear
picture of the hapten-forming process is available to date.
Recently, the oxidation of a PPD derivative to the reactive
benzoquinone diimine (BQDI) formed by air oxygen was
described as a prerequisite for its reaction with proteins
(Eilstein et al., 2006).
Furthermore, the limited knowledge about the relevant
conditions for the conversion of a pro/prehapten such as PPD
into a hapten impaired the interpretation of the PPD-specific
T-cell recognition. Analysis of the primary T-cell response
in vitro indicated that PPD is the prohapten and BB the
hapten, as PPD did not induce a lymphoproliferative
response whereas BB did (Krasteva et al., 1996). In contrast,
& 2009 The Society for Investigative Dermatology www.jidonline.org 99
ORIGINAL ARTICLE
Received 29 January 2008; revised 28 April 2008; accepted 10 May 2008;
published online 14 August 2008
1The Procter and Gamble Co., Wella-Cosmital, Marly, Switzerland;
2The Procter and Gamble Co., Miami Valley Innovation Center, Cincinnati,
Ohio, USA and 3The Procter and Gamble Co., Wella Service GmbH,
Darmstadt, Germany
Correspondence: Dr Carsten Goebel, The Procter and Gamble Co., Wella
Service GmbH, Berliner Allee 65, D-Darmstadt 64274, Germany.
E-mail: goebel.c.1@pg.com
Abbreviations: AQP3, aquaporin 3; BB, Bandrowski’s base, BQDI;
benzoquinone diimine; DC, dendritic cell; LLNA, local lymph node assay;
PPD, p-phenylenediamine; RT, reverse transcriptase
when T cells from PPD- allergic donors were analyzed for
their recognition of PPD itself, restimulation was successful
even if fixed antigen-presenting cells were used, whereas
restimulation by BB was only obtained with functional
antigen-presenting cells (Sieben et al., 2002). More recently,
BB was shown to induce lymphocyte proliferation in PPD-
allergic patients and volunteers, but only lymphocytes from
patients additionally proliferated to PPD, suggesting that PPD
alone or a degradation product other than BB specifically
contributes to the generation of allergic contact dermatitis to
PPD (Coulter et al., 2008).
Apart from the limited understanding of the passive,
nonenzymatic formation of immunogenic PPD, active skin
metabolism of PPD is known to occur following permeation
of PPD through the stratum corneum (Merk et al., 2006).
Under exposure conditions provided by hair dyeing with
PPD, approximately 1.3% of the applied dose is considered
as (bio)available in the epidermis and dermis (Hueber-Becker
et al., 2004). Subsequent analysis of PPD skin metabolism
revealed that under these conditions N-acetylation is the
major metabolic pathway (Kawakubo et al., 2000; Nohynek
et al., 2006) and that epidermal keratinocytes are the
responsible skin cells due to their high content of the
mediating enzyme N-acetyltransferase 1 (Kawakubo et al.,
2000). When the N-acetylated PPD metabolites were
analyzed for their capacity to restimulate T cells from PPD-
allergic patients, no T-cell response was induced (Sieben
et al., 2001), suggesting that N-acetylation represents a
detoxification pathway regarding PPD-induced allergic
contact dermatitis (Merk et al., 2006).
The role of enzymatic oxidation of PPD in the skin remains
unclear, as to our knowledge no corresponding data are
available to date that demonstrate oxidative metabolism of
PPD in the skin. For example, no indication for the generation
of oxidative PPD metabolites was found following skin
exposure to PPD during hair dyeing (Nohynek et al., 2004).
However, enzymatic epidermal oxidation of other sensitizing
low molecular weight chemicals to their immunogenic form
has been reported for cinnamic alcohol (Smith et al., 2000),
eugenol, and isoeugenol (Bertrand et al., 1997).
In the present paper, we asked which putative auto-
oxidation products do occur after exposing PPD (1) to strong
oxidizing conditions to monitor all possible oxidation
products or (2) to air oxygen to mimic oxidative exposure
conditions in vitro (aqueous solution) and in vivo as is the
case in the LLNA. Furthermore, N-acetylated PPD deriva-
tives, representing the main products of active skin metabo-
lism, were synthesized. Subsequently, we investigated the
sensitizing potential of PPD, its oxidation products, and its
N-acetylated derivatives by analyzing their ability to induce
in vitro activation of dendritic cell (DC)-like cells. Such
in vitro DC activation protocol based on the modulation of
specific cell surface markers or cytokine gene expression
patterns by contact sensitizers has been already used in our
laboratory (Aeby et al., 2004) and by others (Bergstro¨m et al.,
2007) to assess the sensitizing potential of low molecular
weight chemicals. Finally, we compared the DC activation
patterns induced by PPD, its oxidative products, and its
N-acetylated derivatives with their ability to induce skin
sensitization in vivo using the LLNA.
RESULTS
Comparison of PPD auto-oxidation products after exposure to
ferrocyanide or to air oxygen
PPD was exposed to ferrocyanide in aqueous media for 30
minutes and the resulting reaction products were investigated
by liquid chromatography/tandem mass spectrometry
(Figure 1). Among the parent compound (PPD at 0.99
minutes), other species could be identified, that is, a second
monomeric structure appeared at 2.22 minutes (possibly
corresponding to BQDI; Figure 1 , top), a dimeric structure at
8.2 minutes (Figure 1 , middle), and three trimeric structures
at 7.3, 8.6 (corresponding to BB, as confirmed by comparison
to the analytical standard), and 9.0 minutes (Figure 1,
bottom).
Eight hours after the addition of PPD to an aqueous
solution constantly saturated with air oxygen by an airflow,
substantial amounts of a putative dimer, of BB and of a
second trimer were detectable, but at smaller quantities
compared to the ferrocyanide oxidation. Correspondingly,
the concentration of PPD decreased to approximately 50% of
the initial concentration (Figure 2).
We further assessed the pH dependency of BB formation
in aqueous solution (Figure 3) to check if the skin surface pH
milieu (pH 5.4–5.9; Schmid-Wendtner and Korting, 2006)
was consistent with the auto-oxidative generation of BB.
Following exposure of PPD to ferrocyanide for 1 hour at pH
4, no BB could be detected whereas at a pH range between 5
and 7 favorable conditions for BB formation were observed,
reaching an optimum at pH 6.
Concentration-dependent activation of DC-like cells by PPD,
oxidized PPD, and BB
In a preliminary experiment, the optimal exposure period was
determined based on the measurement of the proportion of
CD86 bright cells in a population of DC-like cells exposed to
73 and 180 mM fresh PPD, 73 mM ferrocyanide-oxidized PPD,
31.4 mM BB, 243mM monoacetyl PPD, and 190mM diacetyl
PPD. The optimal exposure times were 24 or 30 hours (data
available as online-only Figure S1). Subsequently, DC-like
cells obtained from a pool of four donors were exposed for 24
hours to 30–243 mM fresh PPD, 30–91 mM ferrocyanide-
oxidized PPD, and 0.5–47 mM BB. Higher concentrations
could not be analyzed due to cell toxicity as determined by
flow cytometry measurements of fluorescein diacetate
incorporation. As negative controls, the same volume of
vehicles (25–50 ml H2O for PPD, 25–50 ml H2O containing a
concentration of K4[Fe(CN)6] 3H2O (reduced form of the
oxidizing agent) identical to that of K3[Fe(CN)6]) used for
oxidizing the PPD for the oxidized PPD or 10 ml of DMSO for
BB was tested in parallel.
As activation markers, the proportion of CD86 bright cells,
the upregulation of IL-1b and IL-8 genes, and the down-
regulation of aquaporin 3 (AQP3), a gene known to be
downregulated during DC maturation (de Baey and Lanza-
vecchia, 2000), was measured (Figure 4). BB was the most
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potent inducer of CD86 bright cell population (see Figure 4a),
reaching 528% of the negative control at a concentration of
30 mM. Oxidized PPD was less potent, inducing 209% of the
negative control at a concentration of 61 mM. Fresh PPD was a
comparatively much weaker inducer of the CD86 bright
population, reaching a maximum of 127% of the negative
control at 182 mM (down to 118% at 243mM). Very similar
patterns were observed with the other activation markers
(IL-1b, IL-8, and AQP3; see Figure 4b–d): BB was always the
most potent chemical, inducing 432% of negative control at
15.7 mM (IL-1b), 584% at 47 mM (IL-8), and 37.5% at 30 mM
(AQP3). Oxidized PPD (268% at 61 mM for IL-1b, 285% at
73 mM for IL-8, and 50% at 73 mM for AQP3) was less potent
than BB but nevertheless induced relevant effects at
concentrations much lower than PPD (318% at 243 mM for
IL-1b, 443% at 122 mM for IL-8, and 74% at 243 mM for AQP3).
Concentration-dependent activation of DC-like cells by mono-
and diacetyl PPD
DC-like cells obtained from a pool of four donors were
exposed for 24 hours to 30–243 mM monoacetyl PPD and
65–260 mM diacetyl PPD. Higher concentrations were not
evaluated due to cytotoxic effects as determined by flow
cytometry measurements of fluorescein diacetate incorpora-
tion. As a negative control, 25–100 ml of RPMI, the vehicle
used for preparing the test items, was tested in parallel.
The percentage of CD86 bright population and IL-1b, IL-8,
and AQP3 gene expressions were measured after the 24-hour
exposure period (see Figure 5). Monoacetyl PPD had no
relevant influence on the modulation of the four selected DC
activation markers. Diacetyl PPD had slight effects on the
Figure 1. Typical daughter scan chromatograms obtained of a reaction mixture of PPD in the presence of potassium ferrocyanide after 30 minutes of
reaction time. Top chromatogram represents a potential monomeric species (peak at 2.2 minutes, m/z¼107, typical fragments at m/z¼ 80, 53), possibly
corresponding to benzoquinone diimine. Middle chromatogram represents a potential dimeric species (m/z¼ 198). Bottom chromatogram represents
potential trimeric species (m/z¼ 319, peak at 7.3 and 9.0 minutes), the peak at 8.7 minutes was identified as BB.
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Figure 2. Air oxidation of PPD leads to the formation of dimeric and trimeric
auto-oxidation products including BB. The presence of auto-oxidation
products was analyzed by qualitative HPLC at the indicated time after
addition of PPD to an aqueous solution constantly saturated with air oxygen
by a flow. Peak area values were transformed to arbitrary units (AU).
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Figure 3. PPD oxidation to BB is pH dependent. The presence of BB was
analyzed by qualitative HPLC 1 hour after oxidation of PPD was initiated by
the addition of potassium ferrocyanide at the indicated pH. Peak area values
were transformed to arbitrary units (AU).
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mRNA expression of IL-1b (up to 162% of negative control at
65 mM, without dose–effect relationship) and IL-8 (up to 203%
of negative control at 195 mM). On the other hand, it had no
relevant effect on the percentage of the CD86 bright
population or on AQP3 gene expression. Compared to
PPD, oxidized PPD, and BB, the acetylated forms of PPD
had much less or no effect on the expression of the selected
activation markers.
Evaluation of PPD, BB, mono- and diacetyl PPD in the LLNA
The sensitizing properties of PPD (as free base), mono- and
diacetyl PPD, and BB were evaluated in a standard LLNA
(according to the OECD 429 guideline) by measurement of
cell proliferation in the draining lymph nodes after topical
application on the ears of mice (see Figure 6). The animals
received 25 ml of the test item formulations on each ear on
days 0–2 and were killed on day 5 for assessment of cell
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Figure 4. Concentration-dependent activation of DC-like cells by PPD, oxidized PPD, and BB. DC-like cells were exposed for 24 hours to vehicle alone
(’), to 30–243 mM fresh PPD (K), 30–91 mM oxidized PPD (m), and 0.5–47mM BB (&). (a) Flow cytometry analysis of the CD86 bright population, expressed
as the percent ratio of the negative control. The mean and standard error of the mean are represented; n¼6 independent experiments for PPD and BB and
n¼ 3 for oxidized PPD. (b) Corresponding results for IL-1b gene expression measured by RT–PCR. (c) Corresponding results for IL-8 gene expression
measured by RT–PCR (n¼4 for BB). (d) Corresponding results for AQP3 gene expression (n¼5 for BB).
300250200
400
150100500
μM
300250200150100500
μM
300250200150100500
μM
300250200150100500
μM
300
200
100
0
AQ
P3
 m
RN
A 
(%
 of
 co
ntr
ol±
SE
M
)
400
300
200
100
0
IL
-1
β m
R
N
A 
(%
 of
 co
ntr
ol±
SE
M
)
400
300
200
100
0
IL
-8
 m
RN
A 
(%
 of
 co
ntr
ol±
SE
M
)
400
300
200
100
0C
D8
6 
br
ig
ht
 p
op
ul
at
io
n 
(%
 of
 co
ntr
ol±
SE
M
)
Figure 5. Concentration-dependent activation of DC-like cells by mono- and diacetyl PPD. DC-like cells were exposed for 24 hours to vehicle alone (’), to
30–243mM monoacetyl PPD (J) and 65–260mM diacetyl PPD (,). (a) Flow cytometry analysis of the CD86 bright population, expressed as the percent ratio of
the negative control. The mean and standard error of the mean are represented; n¼ 3 independent experiments. (b) Corresponding results for IL-1b gene
expression measured by RT–PCR. (c) Corresponding results for IL-8 gene expression measured by RT–PCR. (d) Corresponding results for AQP3 gene expression.
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proliferation in the draining auricular lymph nodes. Concen-
trations of 0.1% (B9mM), 0.25% (B23mM), 0.75% (B70mM),
and 2.50% (B230mM) of PPD; 0.35% (B27mM), 1.4%
(B93mM), and 3.5% (B233mM) of monoacetyl PPD; 0.44%
(B21mM), 1.78% (B94mM), and 4.44% (B229mM) of
diacetyl PPD; and 0.01% (B0.3mM), 0.10% (B3mM), 1.0%
(B31mM), and 4.0% (B126mM) of BB in DMSO were
assessed. PPD and BB were able to induce dose-dependent
increases in the LLNA response with EC3 values (calculated by
nonlinear regression) of 0.09% (B10mM) and 0.008%
(B0.3mM), respectively. In contrast, diacetyl PPD tested up
its solubility limit in DMSO and monoacetyl PPD applied
approximately at the same molar concentrations did not induce
a stimulation index above 3 (see Figure 6).
DISCUSSION
In this paper, we investigated the modifications of PPD
following its application onto the skin and its subsequent
penetration through the stratum corneum until reaching the
living epidermis. Specifically, we analyzed the role of
oxidation and N-acetylation as the major PPD transformation
steps, and their significance for activation of the skin immune
system that may result in allergic contact dermatitis.
In a first step, we asked what happens to PPD when
applied to human or rodent skin surface in skin sensitization
studies such as in the guinea pig or LLNA or in a human
diagnostic patch test. The skin surface environment is
expected to provide excellent conditions for the auto-
oxidation of PPD due to its large surface area exposed to
air oxygen. In addition, optimal conditions for skin permea-
tion are provided as skin penetration-enhancing vehicles (for
example, acetone olive oil in the LLNA; see Trommer and
Neubert, 2006) or occlusive conditions (with white petrola-
tum as vehicle for diagnostic patch testing; see Marzulli
and Maibach, 1974; Kim et al., 1987; Basketter et al., 2006;
Bruze et al., 2007) are recommended. The recommended
exposure times of 448 hours and/or repeated applications
support further auto-oxidation and penetration of PPD. To
analyze what happens to PPD under auto-oxidation condi-
tions that are expected to occur on the skin surface, we
measured PPD oxidation in aqueous solution (1) by air
oxygen and (2) under exaggerated conditions using a strong
oxidizer (ferrocyanide). In the presence of air oxygen, we
found that PPD itself is initially stable, but already after 30
minutes a peak of a second monomer was detected. After 30-
minute exposure to strong oxidizing conditions, relatively
high amounts of that monomer (Figure 1) possibly corre-
sponding to BQDI were detectable, and polymerization to
dimeric and trimeric auto-oxidation products, including BB
occurred (Figure 1). A similar spectrum of auto-oxidation
products was detected after 8-hour exposure to air oxygen
(Figure 2). Similar observations concerning BB formation in
aqueous solution (cell culture medium) containing PPD were
made by Coulter et al. (2007, 2008). Moreover, in a recent
work with PPD and p-toluenediamine (Goux et al., 2007),
similar species were detected. Thus, PPD oxidized by
ferrocyanide was used as a source of auto-oxidation products
that are expected to occur on the skin under conditions
similar to those of in vivo skin sensitization tests.
Assuming that, in addition to PPD, its auto-oxidation
products are able to overcome the skin barrier and penetrate
into the epidermis, activation of skin DC (Langerhans cells)
will be required for the induction of skin sensitization.
Therefore, we tested fresh, non-oxidized and oxidized PPD
(that is, the mixture of PPD with ferrocyanide after 30-minute
incubation) as well as BB for their potential to induce in vitro
activation of human immature DC derived from peripheral
blood monocytes (see Figure 4).
BB was the most potent DC activator, inducing a strong
modulation of the four chosen markers at relatively low
concentrations (o30 mM). Pre-oxidized PPD solution, which
contained PPD, BB, BQDI, and other oxidation products
(see Figure 1), was less potent than pure BB, that is, higher
concentrations were needed to induce a relatively weaker
modulation of all tested markers (maximal effects were
observed after exposure to 61 mM of initial PPD). On the other
hand, the fresh PPD solution was a comparatively much
weaker inducer of DC activation. Consequently, the observed
DC activation may not be due to PPD itself but to its
oxidation products formed during the 24-hour incubation
period under the reducing conditions of the culture medium
in presence of living cells. It had no relevant effect on the
CD86 bright population up to the highest subtoxic concen-
tration tested (243 mM). Interestingly, relevant effects were
observed with the other three markers with a sharp increase
at concentration491 mM (see Figure 4). This may be due to a
threshold effect when exceeding the limited reducing
capacity of the culture medium or to the need of a threshold
PPD concentration for forming sufficient auto-oxidation
products of PPD. Interestingly, similar results were obtained
by Toebak et al. (2006) who observed an upregulation of
activation markers such as CD86 and IL-8 at a concentration
range of 50–200 mM and by Hulette et al. (2005) who
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Figure 6. LLNA dose–response of PPD, BB, mono-, and diacetyl PPD. Groups
of mice (n¼ 5) received topical applications on the dorsum of both ears of
25ml of PPD (K), BB (&), monoacetyl PPD (J), or diacetyl PPD (,) in
DMSO at the indicated concentrations for 3 consecutive days. On day 5
following the initiation of the treatment all mice were injected intravenously
with radioactive thymidine and its respective incorporation into the auricular
lymph nodes was measured as described. The arithmetic mean of the
stimulation index and the standard deviation relative to the concurrent
vehicle-treated control is shown for each concentration tested.
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measured a limited CD86 expression after exposure to
2,500mM PPD whereas exposure to BB induced a robust
increase at a much lower concentration (100 mM). On the
basis of these results and on their experiments using a similar
test system, Coulter et al. (2007) proposed concentration-
dependent effects of PPD on DC function, that is, low
concentrations (o50 mM) induce CD40 and major histocom-
patibility complex class II expression, medium concentrations
(p200mM) initiate CXCL8 secretion, whereas concentrations
of 2,500mM and above lead to CD86 expression and strong
cytotoxicity.
Our in vitro results for BB were fully confirmed by LLNA
experiments. As expected, BB induced a vigorous dose-
dependent LLNA response (see Figure 6). The apparent
discrepancy between the weak in vitro DC activation
potential of fresh PPD in the cell culture and its strong
sensitizing potency in the LLNA following application on the
mouse ear (see Figures 4 and 6) is likely explained by the
presumed auto-oxidation conditions prevalent on the skin
surface. Consequently, the strong dose-dependent LLNA
response to PPD is considered equivalent to the relevant
DC activation potential of pre-oxidized PPD.
So far, our data indicate that oxidation is important during
sensitization to PPD as indicated by the strong DC activation
potential of oxidized PPD solution. Non-oxidized PPD has
only a limited potential to activate DCs, probably due to an
initial absence of auto-oxidation products (as present in
oxidized PPD). Over time and with increasing concentra-
tions, DC activation starts to occur in line with the formation
of auto-oxidation products during the 24-hour in vitro
incubation period (Figure 4b and c). This is in agreement
with results from human testing, showing that successful
induction and elicitation of sensitization to PPD is dependent
on dose, duration, and frequency of exposure, that is,
induction of sensitization to 1% PPD in the human repeated
insult patch test decreased from 54 to 3% when the exposure
duration was reduced from 48 hours to 5 minutes (Basketter
et al., 2006). Similarly, elicitation of sensitization to 1% PPD
during patch testing decreased from 69 to 16%, when the
exposure time was reduced from 120 to 5 minutes (Hextall
et al., 2002 and similar in McFadden et al., 1998 and White
et al., 2007). On the basis of our results (Figure 2), an
exposure period of 5 minutes is too short for the formation of
sufficient amounts of auto-oxidation products to cause DC
activation. This is also consistent with the considerable
exposure time-dependent differences in the absorbed con-
centrations of PPD equivalents: after non-rinse exposure for
48 hours to 1% PPD, approximately 20–50% of the applied
patch test dose became absorbed (Kim et al., 1987), whereas
exposure to 2% for 30 minutes and rinse off (hair dyeing
conditions) led to approximately 1.1% absorption and 1.3%
in the epidermis and dermis (Hueber-Becker et al., 2004).
The observation that a spectrum of PPD auto-oxidation
products is probably responsible for the induction of PPD
sensitization is further supported by the finding that human
Langerhans cells exposed to BB, but not PPD, were able to
induce a primary T-cell response in vitro (Krasteva et al.,
1996). Furthermore, T cells from a number of PPD-allergic
patients did not react to PPD, but to BB (Krasteva et al., 1993;
Sieben et al., 2002), and T-cell clones from mice immunized
with a model peptide actively haptenated with PPD (in the
presence of air oxygen) reacted to the same peptide when
haptenated with BB and vice versa (Wulferink et al., 2005)
indicating that a common oxidation product of PPD is
responsible for T-cell recognition. However, in some studies
only a limited number of PPD-allergic patients developed an
elicitation response to BB under patch test conditions (Sieben
et al., 2002; White et al., 2006), probably due to the limited
skin-penetrating properties of BB compared to PPD (Smith
Pease et al., 2005). In more recent experiments (Coulter et al.,
2008), BB formation (prevented by addition of glutathione)
was not required to induce additional proliferation of
lymphocytes from the allergic patients, indicating that BB
might not be necessarily present during elicitation responses,
that is, might not directly be involved in T-cell receptor-
mediated recognition. However, successful induction of a
primary immune response to PPD is dependent on PPD
oxidation to BB (Krasteva et al., 1996), which, based on our
findings is required to provide efficient DC activation and
thus for costimulatory (danger) signaling, that is, the
difference in the magnitude of the danger signal provided
by PPD (low) versus BB/oxidized PPD (high, see Figure 4) is
considered as predominately relevant during the induction
phase of contact sensitization.
BQDI was described to be the first oxidation derivative of
allergenic p-amino aromatic compounds that can directly
react with nucleophilic amino acids and was seriously
considered as a potential candidate for the formation of
antigenic determinants (Eilstein et al., 2006). Our findings
support the view that the formation of a monomer corre-
sponding to BQDI is the starting event to render PPD
immunogenic either by a direct reaction with proteins or by
autoreaction to further haptens such as BB (Figures 1 and 2)
that themselves are protein reactive. For BB, strong protein
reactivity has been already confirmed by Gerberick et al.
(2007) using a peptide reactivity assay. Consequently, these
PPD auto-oxidation products were able to induce DC
activation (Figure 4), a decisive step to initiate an immune
response. The concept with BQDI as the activated monomer
giving rise to common antigenic determinants is also in line
with the frequently observed cross reactivity with other
p-amino aromatic compounds (Uter et al., 2002).
This auto-oxidation scenario of PPD is believed to occur
under most skin sensitization induction and elicitation
protocols and thus helps to explain the strong sensitizing
potency of PPD. Consequently, the DC activation properties
and the sensitizing potency of BB are higher than that of PPD,
as BB is one stable end product of the PPD auto-oxidation
process (Figure 2). This concept is also in line with the
comparatively low EC3 value of BB (0.01%, equivalent to
0.3mM; see Figure 6) and the described ability of BB to
induce primary T-cell responses in vitro (Krasteva et al.,
1996). In patients, the strong linear association between PPD
containing temporary black henna tattoos and strong patch
test reactions (grade þ þ þ ) (Ho et al., 2005) supports our
hypothesis that uncontrolled air oxidation of PPD on the skin
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can lead to very strong allergic reactions, as temporary tattoo
users are exposed to PPD concentrations as high as 15.7% for
several weeks (Brancaccio et al., 2002).
In contrast, when PPD is applied to human skin under
oxidative hair dyeing conditions, PPD is activated by
hydrogen peroxide to BQDI, but the formation of higher
molecular PPD auto-oxidation products is blocked (SCCP,
2005). Instead, the intended reaction to higher molecular,
nonreactive hair coloring molecules is chemically preferred
due to the presence of an excess of couplers (that is,
resorcinols, m-aminophenols, m-phenylenediamines; Brody
and Burns, 1968). When the formation of the final coloring
molecules is completed, up to 1.1% of unconsumed PPD was
found (Rastogi et al., 2006). The recent finding that exposure
to complete PPD containing shades under realistic conditions
for 30 minutes and 1 hour was insufficient to elicit a positive
patch test reaction in PPD-allergic patients that reacted to the
standard diagnostic procedure (48-hour exposure to 1% PPD)
with grade (þ ) or (þ þ ) (Jowsey et al 2006) is in line with
our hypothesis that unmodified PPD is less immunogenic
than PPD auto-oxidation products.
Unconsumed PPD that arrives in the living epidermis
(Hueber-Becker et al., 2004; White et al., 2007) is considered
to predominantly undergo dermal N-acetylation as the
majority is diacetylated when reaching the plasma (Dressler
and Appelqvist, 2006) and more than 80% are mono- or
diacetylated when excreted in the urine following hair dyeing
(Nohynek et al., 2004). This is due to the high capacity of
keratinocytes to N-acetylate PPD and aromatic amines in
general by the mediating enzyme N-acetyltransferase 1
(Kawakubo et al., 1990, 2000; Nohynek et al., 2006). Both,
mono- and diacetylated PPD, were unable to induce DC
activation in vitro (Figure 5) and in vivo (Figure 6) consistent
with the described inability of lymphocytes from PPD-allergic
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O
Figure 7. Comparison of hazard assessing conditions and in-use conditions (hair dyeing) of PPD. In hazard assessment, the skin is exposed to PPD and air
oxygen for 448 hours at pH 5–6, that is, optimal conditions for the auto-oxidation of PPD resulting in the formation of BB and further dimeric and trimeric
oxidation products. The long exposure period further enhances the dermal absorption of PPD and its auto-oxidation products (Kim et al., 1987) that may induce
DC activation and finally allergic contact dermatitis. Under in-use conditions of hair dyeing, the scalp is exposed to PPD for a limited period at high pH, and
PPD auto-oxidation is blocked by an excess of couplers, leading to the controlled generation of the hair coloring, nonreactive reaction products. The short
exposure time leads to a comparatively low dermal absorption of PPD (Hueber-Becker et al., 2004) and of the reaction products (SCCP, 2006). Non-oxidized
PPD that reaches the epidermis is subjected to N-acetylation in keratinocytes, due to their high content of the mediating enzyme N-acetyltransferase 1. The
resulting mono- and diacetylated PPD metabolites have no DC activating potential and are nonsensitizers. For quantities of PPD exceeding the saturation
threshold of N-acetylation, PPD activation by oxidation to protein reactive auto-oxidation products may occur by enzymes such as peroxidase, cyclooxygenase,
or cytochromes P450 (Strohm and Kulkarni, 1986; Sieben et al., 2002; Merk et al., 2006). Consequently, in situations of disturbed barrier function (Proksch and
Brasch, 1997), or deficiencies in cutaneous N-acetylation (Kawakubo et al., 1997) activation of the innate immune system by PPD oxidation products becomes
more likely.
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patients to recognize acetylated metabolites of PPD (Sieben
et al., 2001).
In summary, based on the results obtained with DCs and
the chemical analysis of the auto-oxidation process of PPD in
aqueous solution, we could provide evidence that under
in vivo conditions of prolonged skin exposure (for example,
temporary henna tattoos, LLNA, human diagnostic patch
testing) a substantial quantity of PPD will be air-oxidized on
the skin surface and produce sensitizing auto-oxidation
products possibly with BQDI as initial short-lived intermedi-
ate of the auto-oxidation process (Brody and Burns, 1968;
Goux et al., 2007) that itself is considered as too reactive to
pass the skin barrier (see Figure 7, upper left part). However,
formation of the strong sensitizer BB as one example for a
PPD auto-oxidative end product is very likely, as the normal
skin pH of about 5.7 (Schmid-Wendtner and Korting, 2006)
provides optimal conditions for the stability of BB (Figure 3).
During oxidative hair dyeing, the scalp skin is exposed to
formulations containing PPD and couplers for a short period
(B30 minutes) and the chemistry (pH49) is designed to favor
coupling with couplers, and therefore the formation of di-
and trimeric PPD auto-oxidation products such as BB is
prevented (Brody and Burns, 1968; Bracher et al., 1990;
SCCP, 2005; see Figure 7, upper right part). Furthermore,
there is no exposure to BQDI due to its high reactivity with
couplers to form the hair coloring reaction products (Goux
et al., 2007, Goux et al., follow-up manuscript in prepara-
tion). When non-consumed PPD reaches the epidermis, it
will be metabolized to mono- and diacetylated PPD. For PPD
quantities exceeding the individual capacity for N-acetyla-
tion, we speculate that PPD oxidation to protein reactive
auto-oxidation products may occur by active metabolism (see
Figure 7, bottom). We conclude that the equilibrium between
enzymatic deactivation and activation of PPD is critical for
obtaining an epidermal concentration of activated PPD that
provides effective DC activation needed to induce skin
sensitization.
This paper emphasizes that in vitro DC activation testing
allowed a precise analysis of different sensitizing properties
of chemicals, that is, identifying that PPD itself is nonreactive
in vitro, but needs activation by air oxygen to become
immunogenic.
MATERIALS AND METHODS
Materials
PPD sulfate (CAS no. 16245-77-5) was purchased from Acros
Organics through Chemie Brunschwig AG, Basel, Switzerland.
4-Aminoacetanilide (monoacetyl PPD; CAS no. 122-80-5), 2,4,6-
trinitrobenzenesulfonic acid (CAS no. 2508-19-2) 5% (w/v) solution
in water and potassium hexacyanoferrate(II) trihydrate (K4[Fe(CN)6]
 3H2O; CAS no. 14459-95-1) were purchased from Sigma-Aldrich,
Buchs, Switzerland. Potassium hexacyanoferrate(III) (K3[Fe(CN)6];
CAS no. 13746-66-2) was purchased from Merck (Schweiz) AG
Chemicals, Dietikon, Switzerland. N,N0-Diacetyl-PPD (diacetyl
PPD; CAS no. 140-50-1) and BB (CAS no. 20048-27-5) of
documented purity (approximately 97% by HPLC) were obtained
through our in-house synthesis department.
Culture medium
The culture medium was RPMI 1640 without phenol red (Sigma-
Aldrich) supplemented with 10% fetal calf serum (Amimed,
Allschwil, Switzerland), 2mM L-glutamine (Biochrom KG, Berlin,
Germany), 800Uml1 of rhGM-CSF (Leucomax, Essex Chemie AG,
Luzern, Switzerland) and 1,000Uml1 of IL-4 (Strathmann Biotech
GmbH, Hannover, Germany) referred below as complete culture
medium.
Purification of human monocytes and generation of den-
dritic-like cells. Dendritic-like cells were prepared as described
(Aeby et al., 2004). Briefly, fresh buffy coats were obtained from the
Blutspendedienst SRK Bern AG, Bern, Switzerland according to a
written informed consent agreement signed by the transfusion center
and the first author. An enriched monocytic cell fraction was isolated
by sequential density centrifugations and stored in liquid nitrogen.
Monocyte-derived dendritic-like (DC-like) cells were generated by
thawing and pooling the enriched monocytes from four different
donors and growing them up to 5 days in complete culture medium.
On the fourth day, half of the culture medium was replaced by fresh
medium. The CD1a, CD45, CD86, and HLA-DR phenotypes were
regularly monitored as markers of differentiation into DC-like cells.
At day 4, the DC-like cells were used for the in vitro sensitization
test.
Flow cytometry analysis. Cells were prepared for flow cytometry
analysis by mixing 1 volume of cells (approximately 0.4 106 cells)
with 1 volume of Isoton (Coulter Isoton II diluent, Beckmann Coulter,
Zu¨rich, Switzerland) followed by a 20-minute incubation at 2–8 1C
with the FITC or phycoerythrin-labeled antibodies at concentrations
recommended by the manufacturer. The following antibodies were
used: anti-CD1a-FITC, clone HI149, anti-CD86-FITC, clone
2331(FUN-1) (BD Biosciences, Basel, Switzerland), anti-CD45-
FITC/anti-CD14-PE, clones IMMU19.2 and RMO52 and anti-HLA-
DR-FITC, clone B8.12.2 (Beckman Coulter, Zu¨rich, Switzerland).
Nonspecific staining was determined using relevant isotypic controls
in parallel. Gates based on forward and side scatter signals were set
to exclude most T lymphocytes, dead cells, and debris. Approxi-
mately 10,000 cells were analyzed during each measurement. The
flow cytometry was performed on a Coulter EPICS XL (Beckman
Coulter) analyzer in the FL1 channel at 525 nm for FITC-labeled and
in the FL2 channel at 575 nm for phycoerythrin-labeled antibodies.
Cell viability was determined by measuring the percentage of cells
positive in the FL1 channel (living cells) after 20-minute incubation
with 50 ngml1 fluorescein diacetate (Sigma-Aldrich). The data
analysis was performed with the System II, v. 3.0 software (Beckman
Coulter).
In vitro DC activation test protocol. The tests were performed
as described (Aeby et al., 2004). Briefly, the test items and the
control dissolved in 100ml of vehicle (10 ml for DMSO) are added at
day 4 to 2ml wells containing 1–2 106 cells. After 6 hours, half of
the medium is replaced by fresh complete medium. At the indicated
time points, cells are harvested for reverse transcriptase (RT)–PCR
and flow cytometry analysis as described. In the concentration-
dependent activation experiments, the highest nontoxic concentra-
tion was selected as the upper limit of the dose range (a test item
concentration was considered as nontoxic when the relative cell
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viability reached at least 85% of the respective negative control).
Cell viability is determined by measuring the percentage of cells
positive in the FL1 channel (living cells) after 20-minute incubation
with 50 ngml1 fluorescein diacetate (Sigma-Aldrich).
Three negative controls with an appropriate volume of the
solvent used for the test item are included in each assay for each time
point. In each experiment, one well was treated with 682mM 2,4,6-
trinitrobenzenesulfonic acid as a positive control.
Oxidation of PPD. For the generation of pre-oxidized PPD by
ferrocyanide exposure, 1ml of a 67 mM PPD (13.8mgml1) aqueous
solution was mixed with 1ml of a 134 mM K3[Fe(CN)6]
(44.02. mgml1) solution for 30 minutes at room temperature and
was analyzed. For the experiments with exposure of PPD to air
oxygen, an aqueous solution containing 67 mM PPD was constantly
saturated by sparging air through a fritted gas dispersion tube and
analysis was performed at several time points between 30 minutes
and 8 hours after addition of PPD. For HPLC analysis, a mobile
phase consisting of methanol (Biosolve, Valkenswaard, The
Netherlands), ammonium acetate (Fluka, Buchs, Switzerland, puriss
p.a.), and formic acid (Fluka, HPLC grade) was used. A triple
quadrupole mass spectrometer (Micromass, LC-Quattro) controlled
by the Masslynx software and equipped with an Agilent HPLC (1,100
Series) was used for ESI-MS2 measurements; these were performed in
positive ion mode. Typical instrumental setup used was: 3 kV
capillary gas, 25V cone voltage, 2V extractor cone voltage, and
0.2V radio frequency lens voltage. The source temperature was set
to 120 1C and the desolvation temperature was 600 1C. In the case of
the MS2 experiments, argon was used as collision gas and the
pressure and collision cell parameters were optimized for optimal
intensity of fragments. MS2 spectra were recorded in Daughter ion
mode and total ion current-MS spectra were recorded in full-scan
mode.
PH-dependent oxidation of PPD to BB. PPD was dissolved at
1.5mgml1 in the following standard buffer solutions at the
indicated pH (potassium hydrogen phtalate/NaOH for pH 4, 5,
and 6, potassium dihydrophosphate/sodium hydrophosphate for
pH 7 and sodium tetraborate/HCl for pH 9) at room temperature.
Then, an equimolar amount of potassium ferrocyanide was added
and 1 hour later the samples were analyzed for the presence of BB by
qualitative HPLC analysis as follows: supernatants obtained after
centrifugation were filtered, diluted in HPLC eluent and injected on
an Atlantis column (Waters AG, Baden-Da¨ttwil, Basel, Switzerland)
under isocratic conditions using 0.06M ammonium formiate at
pH 7.5 in 25% acetonitrile at a flow rate of 0.8mlmin1. A diode
array detector (Waters AG) was used and the BB peak area was
measured at 480 nm at 25–26 minutes.
RNA extraction and reverse transcription. Total RNA was
isolated from cell cultures using the TRIzol method (Invitrogen AG,
Basel, Switzerland) according to the manufacturer’s instructions.
Briefly, the cells were pelleted by centrifugation at 600 g for 5
minutes at 2–8 1C. Subsequent reactions took place at 2–8 1C. The
pellet was resuspended in the TRIzol reagent (400 ml per 106 cells),
homogenized by pipetting vigorously, and briefly vortexed. After
addition of chloroform (Fluka; 80ml per 106 cells) the sample was
vortexed, incubated for 5 minutes and centrifuged at 12,000 g for 30
minutes. The aqueous phase containing RNA was transferred to a
new tube and RNA was precipitated with 1 volume isopropanol for
at least 45 minutes (Fluka). The pellet was washed with 75% ethanol
(Fluka) and resuspended in 50 ml TE buffer (Amresco, BioConcept,
Allschwil, Switzerland). The RNA was quantified by OD260
measurement and adjusted to 50 mgml1. Purified total RNA
(450 ng) was reverse transcribed using random hexamers (50 ng per
reaction) using the ThermoScript RT–PCR system (Invitrogen),
according to the instruction manual.
Analysis of gene expression by quantitative PCR (real-time
PCR). The 28S ribosomal RNA (28S rRNA) cDNA was quantified
through real-time PCR on the LightCycler with the kit ‘‘LightCycler—
FastStart DNA Master SYBR Green I’’ (Roche Diagnostics, Rotkreuz,
Switzerland). The oligonucleotide primers for 28S rRNA (GenBank
accession no. M11167) used were 50-CGGTACACCTGTCAAACGG
TAAC-30 and 50-TTAGAGGCGTTCAGTCATAATCCC-30 (Microsynth
GmbH, Balgach, Switzerland). The PCR was carried out in glass
capillaries for 40 cycles according to the manufacturer’s instructions
at a final MgCl2 concentration of 4mM. Briefly, a cycle consisted of a
denaturation for 15 seconds at 95 1C, an annealing for 5 seconds at
65 1C, and an elongation at 72 1C for 21 seconds. The green
fluorescence was detected at the end of each elongation cycle. The
amplification specificity of the PCR products was checked by the
melting curve analysis. The quantification data were then analyzed
with the LightCycler analysis software using the second derivative
maximum method.
The IL-1b, IL-8, and AQP3 cDNAs were quantified with the kit
‘‘Premix Ex Taq (Perfect Real Time)’’ (TaKaRa, AxonLab, Le Mont-sur-
Lausanne, Switzerland), using TaqMan probes purchased from
Applied Biosystems (Rotkreuz, Switzerland) through the website
http://www.appliedbiosystems.com. The probes (TaqMan Gene
Expression Assays) used were IL-1b (assay ID: Hs00174097_m1),
IL-8 (assay ID: Hs00174103_m1), and AQP3 (assay ID:
Hs00185020_m1). The PCR was carried out in glass capillaries at
a final MgCl2 concentration of 3mM for 50 cycles. Briefly, a cycle
consisted of a denaturation for 10 seconds at 95 1C, an annealing/
elongation for 30 seconds at 60 1C. The fluorescence measurement
was detected at the end of each elongation cycle. The quantification
data were then analyzed with the LightCycler analysis software using
the second derivative maximum method. The expression levels of
IL-1b and IL-8 cDNAs were finally normalized to the expression
level of 28S rRNA cDNA by computing the ratio amount of IL-1b and
IL-8 cDNA/amount of 28S rRNA cDNA.
Local lymph node assay. Murine LLNAs were conducted as
described previously (Kimber and Basketter, 1992). Briefly, groups of
mice (n¼ 5) were exposed topically on the dorsum of both ears to
25 ml of various concentrations of the test items, or to the same
volume of the respective vehicle alone, daily for 3 consecutive days.
To achieve maximum solubility, PPD free base (CAS no. 106-50-3;
Sigma-Aldrich), mono- and diacetyl PPD and BB were dissolved in
DMSO on each treatment day and used within 5 hours of
preparation. Five days following the initiation of the treatment, all
mice were injected intravenously via the tail vein with 250 ml of
phosphate-buffered saline containing approximately 20 mCi
3H-methyl-thymidine. After 5 hours mice were killed by carbon
dioxide inhalation and draining auricular lymph nodes were excised
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and pooled for each animal. Cells were washed twice with
phosphate-buffered saline and precipitated in 5% trichloroacetic
acid at 4 1C overnight. Pellets were then resuspended in 1ml of 5%
trichloroacetic acid and transferred into scintillation vials. Incor-
poration of 3H-methyl-thymidine was measured by b-scintillation
counting as disintegrations per minute per node for each animal. In
each case a stimulation index relative to the concurrent vehicle-
treated control was derived. For calculating the EC3 values for BB
and PPD, respectively, nonlinear regression with curve fit (GraphPad
Prism 3.0) was used. All procedures were performed in AAALAC
(Association for Assessment and Accreditation of Laboratory Animal
Care) International accredited facilities and conducted in
accordance with the National Research Council’s Guide for the
Care and Use of Laboratory Animals.
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